Cancer survivors are more likely than their healthy counterparts to be currentsmokers, to rate their overall health as "poor," and to report less participation in moderate to strenuous exercise according to the results of a study from the Mayo Clinic.
Cancer survivors are more likely than their healthy counterparts to be current smokers, to rate their overall health as "poor," and to report less participation in moderate to strenuous exercise, according to the results of a study from the Mayo Clinic.
The authors reviewed the health behaviors and previous cancer histories of 18,510 women age 35 years and older presenting for screening mammography. Almost 15% of the women reported a cancer history. Only 13.6% of the cancer survivors compared with 21.5% of the women without a cancer history reported their health as "excellent." Similarly, they were more likely to rate their overall health as poor (15.8% vs 9.1%, respectively).
Compared with 63.3% of women who never had cancer, 56.5% of the cancer survivors reported engaging in regular moderate or strenuous exercise. Cancer survivors, particularly those between the ages of 30 and 49, were more likely to smoke than those who never had cancer (6.3% vs 5.5%, respectively) and they were less likely than noncancer participants to use alcohol monthly or more frequently (66.9% vs 71.4%). Younger survivors (age 30 to 49 years) were the most frequent (79.2%) regular drinkers, defined as at least one drink per month.
Rausch SM, Millay S, Scott C, et al. Health behaviors among cancer survivors receiving screening mammography. Am J Clin Oncol. 2012;35(1):22-31.
Study: Plant-based diets lower hypertensive disorders of pregnancy risk
March 28th 2024A recent study suggests that adherence to plant-based diets significantly decreases the risk of developing hypertensive disorders of pregnancy, shedding light on dietary interventions for maternal health.
Read More
How genetic variables impact oral contraceptive use and VTE risk
March 27th 2024A comprehensive study delved into the interplay of polygenic and hereditary factors in venous thromboembolism risk among oral contraceptive users, shedding light on potential genetic markers for refined risk assessment and counseling.
Read More